Samenvatting lessen MBK deel v. Cutsem

Vrije Universiteit Brussel



Beginselen van
de
kinesitherapie
Prof. Van Cutsem




[Nom de l’auteur]
26/09/2019

,Inhoudstafel
1. Gezondheidsleer & epidemiologie......................................................................................................4
1.1. Gezondheid..................................................................................................................................4
1.2. Ziekte...........................................................................................................................................4
1.3. Gezondheidsleer..........................................................................................................................6
1.3.1 Indeling gezondheidsleer.......................................................................................................6
1.3.2 Preventie bij preventieve geneeskunde.................................................................................6
1.4. Revalidatieleer.............................................................................................................................6
1.5. Epidemiologie..............................................................................................................................7
1.5.1 Ziekte- en sterftebeschrijving................................................................................................7
1.5.2 Tijdsperiode:..........................................................................................................................7
1.5.3 Risico van de ziekte:...............................................................................................................7
1.5.4 Epidemiologische studie designs...........................................................................................8
1.5.5 Methode om ziekte vroegtijdig op te sporen.........................................................................8
1.5.6 Testeigenschappen................................................................................................................8
2 Cardiovasculaire aandoeningen...........................................................................................................8
2.1 Circulatoire aandoeningen............................................................................................................8
2.1.1 Onderverdeling......................................................................................................................8
2.1.2 Kransslagaderziekte...............................................................................................................9
2.1.3 Congestief hartfalen..............................................................................................................9
2.2 Mortaliteit....................................................................................................................................9
2.3 Risicofactoren.............................................................................................................................10
2.4 Preventie bij intrinsieke risicofactoren.......................................................................................10
3 Cerebrovasculair accident.................................................................................................................11
3.1 Symptomatologie.......................................................................................................................11
3.2 Pathogenese...............................................................................................................................11
3.3 Prognose.....................................................................................................................................11
3.4 Risicofactoren.............................................................................................................................12
3.5 Revalidatie..................................................................................................................................12
3.6 Take Home Messages.................................................................................................................12
4 Respiratoire aandoeningen...............................................................................................................12
4.1 COPD...........................................................................................................................................12
4.2 Definitie......................................................................................................................................13
4.3 Symptomen COPD......................................................................................................................13
4.4 Mortaliteit..................................................................................................................................13

1

, 4.5 Diagnose.....................................................................................................................................13
4.6 Sensitivity & Specificity...............................................................................................................14
4.7 Risicofactoren.............................................................................................................................14
4.8 Rol van de kinesitherapeut.........................................................................................................14
4.9 Evidence based kinesitherapie....................................................................................................15
5 Kanker................................................................................................................................................15
5.1 Functioneren gezonde cel...........................................................................................................15
5.2 Goedaardig gezwel.....................................................................................................................15
5.3 Schadelijke gevolgen...................................................................................................................15
5.3.1 Soorten gezwellen...................................................................................................................16
5.4 Kwaadaardig gezwel...................................................................................................................16
5.5 Schadelijke gevolgen...................................................................................................................17
5.5.1 Soorten gezwellen...............................................................................................................18
5.6 Evidence based kinesitherapie....................................................................................................18
6 Diabetes Mellitus...............................................................................................................................19
6.1 Definitie.....................................................................................................................................19
6.2 Insuline.......................................................................................................................................19
6.2.2 Type 2 patiënt:.....................................................................................................................19
6.3 Pathogenese T1..........................................................................................................................19
6.4 Pathogenese T2..........................................................................................................................20
6.5 Zwangerschapsdiabetes..............................................................................................................20
6.6 Mortaliteit..................................................................................................................................20
6.7 Prevalentie..................................................................................................................................20
6.8 Symptomatologie:......................................................................................................................20
6.8.1 Moeilijkheden met glycemische controle............................................................................21
6.9 Behandeling................................................................................................................................22
6.10 Behandeling T1.........................................................................................................................22
7 Gewrichtsaandoeningen....................................................................................................................23
7.1 Artrose en Artritis.......................................................................................................................23
7.2 Reumatoïde artritis.....................................................................................................................23
7.2.1 Behandeling als kine............................................................................................................24
7.3 Osteoporose...............................................................................................................................24
7.3.1 Functie skelet.......................................................................................................................25
......................................................................................................................................................25
7.3.2 Etiologie...............................................................................................................................25
7.4 Letsels aan de wervelkolom........................................................................................................25

2